About this trial
COPD is a preventable and treatable lung disease characterized by persistent and progressive airflow limitation. PRISm, on the other hand, is a spirometry pattern that does not meet COPD diagnostic criteria despite symptoms and functional impairments, but requires maintenance. PRISm can predispose to the development of COPD and exacerbations, and can reduce exercise capacity by reducing respiratory function and oxygen consumption. There are no studies in the literature comparing respiratory muscle strength, peripheral muscle strength, and oxygenation in PRISm, COPD, and healthy individuals. Therefore, this study aimed to evaluate these parameters and compare them with healthy individuals.
Eligibility criteria
Qualifiers
Being >40 years old,
Being diagnosed with COPD,
Being clinically stable,
Volunteering to participate in the study.
Disqualifiers
Having severe orthopedic, neurological, or cardiac diseases,
Being in a COPD exacerbation,
Having a comorbid lung disease,
Being on clinically unstable medication,
Trial design
Treatments tested in this trial
- Not listed